Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check4 days agoChange DetectedThe page now includes new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and introduces an 'Intervention/Treatment' header as part of a layout update; it also adds a recruitment note 'No longer looking for participants' and a site revision tag 'Revision: v3.6.0'.SummaryDifference0.5%

- Check11 days agoChange DetectedA new page revision tag (v3.5.5) is now shown, replacing the previous v3.5.4. This reflects a platform update rather than any changes to the study details or user-facing content.SummaryDifference0.0%

- Check18 days agoChange DetectedThe study page now includes Schizophrenia as a related topic and adds a related topics section featuring MedlinePlus Genetics.SummaryDifference0.1%

- Check25 days agoChange DetectedSchizophrenia is no longer listed as the study's condition, and the Related Topics header along with the MedlinePlus Genetics link have been removed, reducing contextual labels and external references on the page.SummaryDifference0.1%

- Check32 days agoChange DetectedSchizophrenia and MedlinePlus Genetics were added to the related topics area, and the site revision now shows Revision: v3.5.4. The previous revision label v3.5.3 was removed.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page adds an expanded related topics section, listing Schizophrenia and MedlinePlus Genetics under related topics. This connects the study to broader schizophrenia- and genetics-related resources for readers.SummaryDifference0.1%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.